SEC Form 4 · accession 0001140361-16-070886
Raptor Pharmaceutical Corp · RPTP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher M Starr
Director
Period of report
Jun 23, 2016
Accepted (ET)
Jun 27, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070698
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 23, 2016 | A | 8,330 | $0.00 | A | 714,395 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes 8,330 Restricted Stock Units ("RSUs"). The Reporting Person is entitled to one (1) share of common stock for each one (1) RSU upon the vesting thereof. The RSUs will vest in full on June 23, 2017.